Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 21;27(1):41.
doi: 10.1007/s12017-025-08846-0.

Deregulation of Neuroinflammatory and Neurotrophic Factors as Biological Events Triggered by D-Galactose Chronic Administration in Wistar Rats

Affiliations

Deregulation of Neuroinflammatory and Neurotrophic Factors as Biological Events Triggered by D-Galactose Chronic Administration in Wistar Rats

Eduarda Behenck Medeiros et al. Neuromolecular Med. .

Abstract

The chronic administration of D-galactose (D-gal) is widely used to model brain senescence in rodents. However, the effects of prolonged oral exposure of D-gal on the neuroinflammatory cytokines in rats remain poorly characterized. Therefore, we administered D-gal (100 mg/kg) in male Wistar rats aged 3-4 months, via oral gavage once a day for 1, 2, 4, 6, or 8 weeks. Cytokine and neurotrophin levels were analyzed using the ELISA method. D-gal administrations for 4, 6, and 8 weeks significantly increased interleukin -1β (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-4 (IL-4) levels in the frontal cortex and hippocampus. In addition, 4, 6, and 8 weeks of D-gal administration significantly increased interleukin-10 (IL-10) levels in the frontal cortex; however, in the hippocampus, only 6 and 8 weeks of D-gal administration significantly increased the IL-10 levels. In terms of neurotrophin levels, our results demonstrated that 1 week of D-gal administration significantly increased Brain-derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in the hippocampus. In the frontal cortex, D-gal increased BDNF levels when administered for 1 and 2 weeks and increased NGF levels when administered for only 2 weeks. However, we observed a reduction of BDNF, NGF, and Glial cell line-derived Neurotrophic Factor (GDNF) levels after 6 and 8 weeks of D-gal treatment in the frontal cortex. Moreover, GDNF levels also were reduced after 4 weeks of D-gal administration. These findings suggest that oral D-gal exposure disrupts the balance of cytokines and neurotrophins, which may be an essential mechanism in brain aging and neurodegenerative processes.

Keywords: Aging; D-galactose; Inflammatory cytokine; Neurotrophins; Senescence.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests. Ethical Approval: Attached in the supplementary material. Consent to Participate: Not applicable. Consent for Publication: Not applicable.

Similar articles

References

    1. Ali, A., Shah, S. A., Zaman, N., Uddin, M. N., Khan, W., Ali, A., Riaz, M., & Kamil, A. (2021). Vitamin D exerts neuroprotection via SIRT1/nrf-2/ NF-kB signaling pathways against D-galactose-induced memory impairment in adult mice. Neurochemistry International, 142, 104893. https://doi.org/10.1016/j.neuint.2020.104893 - DOI - PubMed
    1. Azman, K. F., & Zakaria, R. (2019). D-Galactose-induced accelerated aging model: An overview. Biogerontology, 20(6), 763–782. https://doi.org/10.1007/s10522-019-09837-y - DOI - PubMed
    1. Biane, J., Conner, J. M., & Tuszynski, M. H. (2014). Nerve growth factor is primarily produced by GABAergic neurons of the adult rat cortex. Frontiers in Cellular Neuroscience, 8, 220. https://doi.org/10.3389/fncel.2014.00220 - DOI - PubMed - PMC
    1. Budni, J., Bellettini-Santos, T., Mina, F., Garcez, M. L., & Zugno, A. I. (2015). The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease. Aging and Disease, 6(5), 331–341. https://doi.org/10.14336/AD.2015.0825 - DOI - PubMed - PMC
    1. Budni, J., Braga Brandão, A., da Silva, S., Lima Garcez, M., Mina, F., Bellettini-Santos, T., Casagrande Zabot, G., Behenck Medeiros, E., Scaini, G., de Oliveira, J., Streck, E. L., & Quevedo, J. (2021). Oral administration of D-galactose increases brain tricarboxylic acid cycle enzymes activities in Wistar rats. Metabolic Brain Disease, 36(5), 1057–1067. https://doi.org/10.1007/s11011-021-00682-y - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources